Noticias de RXRX_US

Noticias del mercado

Últimas noticias sobre RXRX_US — 169 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: RXRX_US ✕ 169 resultados
07/04/2026 RXRX_US — Stock Titan
RXRX (NASDAQ: RXRX) Form 144: 30,000 Class A sale notice
06/04/2026 RXRX_US — Yahoo Finance
Recursion Pharmaceuticals Inc. (RXRX) Partners with Citeline to Develop AI-Powered ClinTech Platform
02/04/2026 RXRX_US — Stock Titan
Recursion (NASDAQ: RXRX) director granted 4,902 Class A shares as compensation
02/04/2026 RXRX_US — Yahoo Finance
Recursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to Know
02/04/2026 RXRX_US — Stock Titan
Director at Recursion (NASDAQ: RXRX) awarded 3,268 shares
29/03/2026 RXRX_US — Stock Titan ES ← EN
Presentación de RXRX ante la SEC: Recursion Pharmaceuticals, Inc. Formularios 10-K, 10-Q, 8-K
27/03/2026 RXRX_US — Yahoo Finance
Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?
27/03/2026 RXRX_US — Stock Titan
Vanguard disaggregates holdings; (RXRX) Schedule 13G/A shows 0 shares
27/03/2026 RXRX_US — Yahoo Finance
Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market
27/03/2026 RXRX_US — Investing.com ES ← EN
Las acciones de Recursion Pharmaceuticals alcanzan su mínimo de 52 semanas a 2,98 dólares
25/03/2026 RXRX_US — Stock Titan ES ← EN
[Formulario 4] RECURSION PHARMACEUTICALS, INC. Actividad de uso de información privilegiada
22/03/2026 RXRX_US — MarketBeat
Recursion Pharmaceuticals Details AI-Driven Drug Pipeline, Sanofi/Roche Milestones, Runway to 2028
21/03/2026 RXRX_US — Yahoo Finance
Recursion Pharmaceuticals Details AI-Driven Drug Pipeline, Sanofi/Roche Milestones, Runway to 2028
19/03/2026 RXRX_US — Yahoo Finance
Recursion Pharmaceuticals (RXRX) Advances While Market Declines: Some Information for Investors
13/03/2026 RXRX_US — Yahoo Finance
Jim Cramer on Recursion Pharmaceuticals: “It’s a Let Down, Big Let Down”
13/03/2026 RXRX_US — MSN
Jim Cramer on Recursion Pharmaceuticals: “It’s a let down, big let down”
12/03/2026 RXRX_US — Sahm
A Look At Recursion Pharmaceuticals (RXRX) Valuation After Q4 Beat And AI Clinical Progress
10/03/2026 RXRX_US — Yahoo Finance
Recursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
09/03/2026 RXRX_US — Finviz
What Makes Recursion Pharmaceuticals (RXRX) So Attractive
09/03/2026 RXRX_US — Yahoo Finance
What Makes Recursion Pharmaceuticals (RXRX) So Attractive

Página 7 de 9

keyboard_arrow_up